Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Pigmented lesions

Derm Cases · Dermatology / Pigmented lesions

OSCE — moles and special naevi: classification, dermoscopy patterns and biopsy thresholds

An 8-minute OSCE station on acquired vs congenital melanocytic naevi, special subtypes (Spitz, blue, halo), age-related dermoscopy patterns, ABCDE/ugly-duckling triage, and biopsy thresholds.

8 minosce2 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on acquired vs congenital melanocytic naevi, special subtypes (Spitz, blue, halo), age-related dermoscopy patterns, ABCDE/ugly-duckling triage, and biopsy thresholds.

Brief (to candidate)

A 28-year-old woman requests mole review. She has multiple stable brown naevi, a pink hairless papule on a child’s arm (brought by her son), and a history of a large congenital naevus in a relative. She asks which moles are safe to leave and which need excision. You have 8 minutes to classify naevi, apply triage rules, and set biopsy/surveillance thresholds.

[5]

Candidate instructions

  1. Classify acquired naevi (junctional / compound / intradermal) and maturation concept.
  2. Outline dermoscopy patterns by age (globular / reticular / homogeneous).
  3. Apply ABCDE and ugly-duckling rules.
  4. Discuss Spitz, blue, and halo naevi management concepts.
  5. Address congenital melanocytic naevus size risk and when MRI/surveillance matters.
  6. State preferred biopsy approach when melanoma cannot be excluded.
[3]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
ClassificationAcquired (junctional → compound → intradermal maturation); congenital (small/medium/large-giant); special types (Spitz, blue, halo/Sutton, dysplastic)[4]
Dermoscopy patternsAge-linked benign patterns (often globular in children, reticular young adults, homogeneous older adults); chaos/clues or atypical features prompt action rather than indefinite observation
Triage rulesABCDE + ugly duckling for changing or outlier lesions; photography/serial monitoring for stable typical naevi
Spitz conceptPink-red dome-shaped papule in child = Spitz spectrum; excisional biopsy preferred when diagnosis uncertain because Spitzoid melanoma must be excluded; histopathology may need expert review[1][6]
Congenital naeviRisk rises with size (large/giant CMN); melanoma can arise within CMN; giant CMN — consider neurocutaneous melanosis risk and imaging/neurology pathway per size and symptoms; shared decision on excision vs surveillance[3][5]
Biopsy / genetics noteFull-thickness excisional biopsy with narrow margins preferred for suspicious pigmented lesions; multiple atypical naevi + family melanoma history → consider hereditary melanoma counselling (e.g. CDKN2A context)[2]
CommunicationReassure most moles are benign; teach self-skin exam and urgent return for change

Model key actions

  • Reassure regarding stable typical acquired naevi; escalate ugly duckling / ABCDE lesions.[4]
  • Manage suspected Spitz with complete excision rather than partial shave when feasible.[1][6]
  • Risk-stratify congenital naevi by size and counsel surveillance/specialist input.[5]

Common errors

  • Excising every mole cosmetically without diagnostic criteria.
  • Partial superficial sampling of a changing pigmented lesion.
  • Dismissing childhood pink papules without considering Spitz spectrum.
[4]
  • Ignoring size-based risk in giant congenital naevi.
  • Missing family-history clues for hereditary melanoma predisposition.
References6ShowHide
  1. [1]Brown A, Sawyer JD, Neumeister MW. Spitz Nevus: Review and Update. Clinics in plastic surgery, 2021.PMID 34503728
  2. [2]Toussi A, Mans N, Welborn J, et al. Germline mutations predisposing to melanoma. Journal of cutaneous pathology, 2020.PMID 32249949
  3. [3]Alos L, Carrasco A, Teixidó C, et al. Melanoma on congenital melanocytic nevi. Pathology, research and practice, 2024.PMID 38518732
  4. [4]Yeh I. Melanocytic naevi, melanocytomas and emerging concepts. Pathology, 2023.PMID 36642570
  5. [5]Mologousis MA, Tsai SY, Tissera KA, et al. Updates in the Management of Congenital Melanocytic Nevi. Children (Basel, Switzerland), 2024.PMID 38255375
  6. [6]Yeh I, Busam KJ. Spitz melanocytic tumours - a review. Histopathology, 2022.PMID 34958498
PreviousOSCE — Meltzer triad and cold-precipitating immunoglobulins: manage cryoglobulinaemic diseaseDermatology / Haematology / HepatologyNextOSCE — two-step dermoscopy algorithm: melanocytic vs non-melanocytic and melanoma cluesDermatology / Pigmented lesions